21-Gene Assay Guides Chemotherapy in Node-Positive Breast Cancer
Recurrence score of 25 or lower predicts benefit of adjuvant chemo for premenopausal, but not postmenopausal, women with N1 breast cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.